Americo Negrette and Huntington's disease

被引：5
作者：
Moscovich, Mariana [1 ]
Munhoz, Renato P. [1 ]
Becker, Nilson [1 ]
Barbosa, Egberto Reis [2 ]
Espay, Alberto J. [3 ]
Weiser, Roberto [4 ]
Teive, Hello A. G. [1 ]
机构：
[1] Univ Fed Parana, Hosp Clin, Dept Internal Med, Neurol Serv,Movement Disorders Unit, BR-80060000 Curitiba, Parana, Brazil
[2] Univ Sao Paulo, Sch Med, Dept Neurol, Movement Disorders Unit, Sao Paulo, Brazil
[3] Univ Cincinnati, Dept Neurol, Gardner Family Ctr Parkinsons Dis & Movement Diso, Cincinnati, OH USA
[4] Inst Clin, Dept Neurol, Caracas, Venezuela
来源：
ARQUIVOS DE NEURO-PSIQUIATRIA | 2011年 / 69卷 / 04期
关键词：
Americo Negrette; Huntington's disease; chorea; huntingtin; CAG;
D O I：
10.1590/S0004-282X2011000500025
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
The authors present a historical review of the seminal clinical contribution of Professor Americo Negrette, a Venezuelan neurologist, to the evolution of scientific knowledge about Huntington's disease.
引用
收藏
页码：711 / 713
页数：3
相关论文
共 50 条
  • [21] Huntington's disease: Neuropsychiatric manifestations of Huntington's disease
    Goh, Anita M. Y.
    Wibawa, Pierre
    Loi, Samantha M.
    Walterfang, Mark
    Velakoulis, Dennis
    Looi, Jeffrey C. L.
    AUSTRALASIAN PSYCHIATRY, 2018, 26 (04) : 366 - 375
  • [22] Calpain activation in Huntington's disease
    Gafni, J
    Ellerby, LM
    JOURNAL OF NEUROSCIENCE, 2002, 22 (12) : 4842 - 4849
  • [23] Huntington's Disease: A Clinical Review
    Andhale, Rajeshwar
    Shrivastava, Deepti
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (08)
  • [24] The endocannabinoid system in Huntington's disease
    Pazos, M. R.
    Sagredo, O.
    Fernandez-Ruiz, J.
    CURRENT PHARMACEUTICAL DESIGN, 2008, 14 (23) : 2317 - 2325
  • [25] Emerging therapies in Huntington?s disease
    Bashir, Hassaan
    EXPERT REVIEW OF NEUROTHERAPEUTICS, 2019, 19 (10) : 983 - 995
  • [26] Investigational drugs for the management of Huntington's disease: are we there yet?
    Kulkarni, Pushkar
    Saxena, Uday
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2014, 23 (12) : 1595 - 1603
  • [27] Molecular Basis of Huntington's Disease and Brain Imaging Evidence
    Plerou, Antonia
    Bobori, Catherine
    Vlamos, Panayiotis
    2015 IEEE INTERNATIONAL SYMPOSIUM ON SIGNAL PROCESSING AND INFORMATION TECHNOLOGY (ISSPIT), 2015, : 387 - 391
  • [28] Iron dysregulation in Huntington's disease
    Muller, Michelle
    Leavitt, Blair R.
    JOURNAL OF NEUROCHEMISTRY, 2014, 130 (03) : 328 - 350
  • [29] Cognitive deterioration in Huntington's disease
    Redondo-Vergé, L
    REVISTA DE NEUROLOGIA, 2001, 32 (01) : 82 - 85
  • [30] Hypersexual features in Huntington's disease
    Jhanjee, A.
    Anand, K. S.
    Bajaj, B. K.
    SINGAPORE MEDICAL JOURNAL, 2011, 52 (06) : E131 - E133
12345